Gating strategy for CD8 + T cells in the dLN, PBL, and tumor. (A)... | Download Scientific Diagram
Positive expression of mesenchymal stem cell markers (CD105, CD73,... | Download Scientific Diagram
Pan T cells (mouse) | Miltenyi Biotec | Deutschland
Frontiers | Key Factors for Thymic Function and Development
CD90 (Thy-1) Monoclonal Antibody (eBio5E10 (5E10)), PE-Cyanine5 (15-0909-42)
Identification of a Hierarchy of Multipotent Hematopoietic Progenitors in Human Cord Blood - ScienceDirect
T Lymphocyte Potential Marks the Emergence of Definitive Hematopoietic Progenitors in Human Pluripotent Stem Cell Differentiation Cultures - ScienceDirect
NK1.1+ CD8+ T cells escape TGF-β control and contribute to early microbial pathogen response | Nature Communications
Gene expression profiles and IL-17A expression of CD8 + CD90 + T cells.... | Download Scientific Diagram
Frontiers | CD90 is not constitutively expressed in functional innate lymphoid cells
FOXP3 expression diversifies the metabolic capacity and enhances the efficacy of CD8 T cells in adoptive immunotherapy of melanoma: Molecular Therapy
Frontiers | Naïve Primary Mouse CD8+ T Cells Retain In Vivo Immune Responsiveness After Electroporation-Based CRISPR/Cas9 Genetic Engineering
CD90-targeted lentiviral vectors for HSC gene therapy: Molecular Therapy
IJMS | Free Full-Text | Generation of Hematopoietic-Like Stem Cells from Adult Human Peripheral Blood Following Treatment with Platelet-Derived Mitochondria
Very Bright Antibody to Detect CD90.1 Congenic Marker on T Cells | Biocompare Antibody Review
Inflammatory CD4/CD8 double positive human T cells arise from reactive CD8 T cells and are sufficient to mediate GVHD pathology | bioRxiv
Immunohistochemical staining for human CD90 in different grades of... | Download Scientific Diagram
Comparative flow cytometry analyses of CD4 + CD90 + T cells and Th17... | Download Scientific Diagram
Frontiers | Thy-1 (CD90) Signaling Preferentially Promotes RORγt Expression and a Th17 Response
JCI Insight - CX3CR1–CD8+ T cells are critical in antitumor efficacy but functionally suppressed in the tumor microenvironment
CD90.2 (Thy-1.2) Monoclonal Antibody (53-2.1), APC (17-0902-82)
